戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 DNs, 1 cholangiocarcinoma, and 1 epithelioid hemangioendothelioma.
2 ell-established murine models for kaposiform hemangioendothelioma.
3 ogic examination revealed a type I infantile hemangioendothelioma.
4 tatin, an angiogenesis inhibitor produced by hemangioendothelioma.
5 ile and congenital hemangiomas to kaposiform hemangioendothelioma.
6 erritt phenomenon associated with kaposiform hemangioendotheliomas.
7  syndrome [BCS], and 10 supposed epithelioid hemangioendothelioma, 1 with BCS), acute BCS of unknown
8 -CAMTA1 (WC) fusion gene defines epithelioid hemangioendothelioma, a malignant vascular cancer.
9 ffii genotype II from a boy with epithelioid hemangioendothelioma and a dog with hemangiopericytoma.
10                             Using a panel of hemangioendothelioma and angiosarcoma cell lines, we dem
11 giostatin was administered to mice with s.c. hemangioendothelioma and associated disseminated intrava
12                                   Kaposiform hemangioendothelioma and tufted angioma are less common
13 s on more aggressive vascular tumors such as hemangioendotheliomas and angiosarcomas, revealing beta
14 ovel, less toxic means of treating infantile hemangioendotheliomas and perhaps other cutaneous vascul
15  the presentation and treatment of infantile hemangioendotheliomas and the differential diagnosis of
16  vascular tumors (0 of 3 hemangiomas, 0 of 1 hemangioendothelioma, and 0 of 1 angiosarcoma).
17                    Angiosarcoma, epithelioid hemangioendothelioma, and Kaposi sarcoma are classified
18 mangiomas, 11 (7.5%) had hepatic epithelioid hemangioendotheliomas, and 20 (13.6%) were classified as
19                                              Hemangioendotheliomas are categorized as intermediate-gr
20 stably expressed Prox1 cDNA in the two mouse hemangioendothelioma cell lines EOMA and Py-4-1, well-es
21 pport the importance of the Hippo pathway in hemangioendothelioma cell proliferation and survival and
22 s H3 and H4 in shear-stressed but not static hemangioendothelioma cells.
23                                  Epithelioid hemangioendothelioma (EH) is a rare, low-grade, malignan
24                                  Epithelioid hemangioendothelioma (EHE) is a difficult to treat vascu
25                                  Epithelioid hemangioendothelioma (EHE) is a genetically homogenous v
26                                  Epithelioid hemangioendothelioma (EHE) is a poorly understood and de
27                                  Epithelioid hemangioendothelioma (EHE) is a vascular sarcoma that me
28 eceptor (VEGFR) in angiosarcoma, epithelioid hemangioendothelioma (EHE), and hemangiopericytoma/solit
29  the proliferation and apoptosis of a murine hemangioendothelioma (EOMA) cell.
30 ally isolated from the conditioned medium of hemangioendothelioma (EOMA) cells.
31 ed originally in conditioned media of murine hemangioendothelioma (EOMA) cells.
32     Epithelioid sarcomalike (pseudomyogenic) hemangioendothelioma (ES-H) is a recently described and
33                A recent review of kaposiform hemangioendothelioma finds that an associated coagulopat
34                                              Hemangioendothelioma (HE) is a type of angiomatous lesio
35 icult differential diagnosis between HAS and hemangioendothelioma (HE), the study was deliberately re
36                          Hepatic epithelioid hemangioendothelioma (HEHE) is a rare vascular tumor whi
37                          Hepatic epithelioid hemangioendothelioma (HEHE) is a rare vascular tumor wit
38 lay a role in the development of epithelioid hemangioendothelioma in immunocompetent patients.
39 congenital tufted angiomas (TAs), kaposiform hemangioendotheliomas (KHEs), and childhood lobular capi
40                                Using a mouse hemangioendothelioma model, we investigated the efficacy
41  human angiostatin administration in a mouse hemangioendothelioma model.
42 angiocarcinoma: n = 2, malignant epithelioid hemangioendothelioma: n = 1, gallbladder cancer: n = 1 o
43 1080 fibrosarcoma, and 6.6% +/- 0.9 for EOMA hemangioendothelioma (P <.01).
44 bacteremia was documented in two epithelioid hemangioendothelioma patients and B. koehlerae bacteremi
45  months, 8 months, and 6 months were seen in hemangioendothelioma, Sertoli-Leydig cell tumor, and fib
46 ally variable natural history of epithelioid hemangioendothelioma, these results suggest that chronic
47 rcinoma, HT1080 human fibrosarcoma, and EOMA hemangioendothelioma--were implanted in nude mice.